Year archive

JW (Cayman) Therapeutics Co. Ltd — 2024 filings

All 39 regulatory filings released by JW (Cayman) Therapeutics Co. Ltd (2126) in 2024, sourced directly from the official regulator.

39 Filings

2024 Period

2024 filings (39)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-05	English
CHANGE OF AUDITOR Board/Management Information	2024-10-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-07	English
2024 INTERIM REPORT Interim / Quarterly Report H1 2024	2024-09-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Share Issue/Capital Change	2024-09-05	English
GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARE UNITS Capital/Financing Update	2024-09-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-08-28	English
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES Board/Management Information	2024-08-28	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report H1 2024	2024-08-28	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE NMPA ACCEPTANCE OF SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION OF CARTEYVA IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY MENTLE CELL LYMPHOMA Regulatory Filings	2024-08-27	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-08-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-05	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-07-31	English
CHANGE OF CHIEF EXECUTIVE OFFICER, APPOINTMENT, REDESIGNATION AND RESIGNATION OF DIRECTORS, CHANGE OF COMPOSITION OF BOARD COMMITTEES AND CHANGE OF AUTHORIZED REPRESENTATIVE Board/Management Information	2024-07-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-03	English
NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2024-06-18	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 18, 2024 Declaration of Voting Results & Voting Rights Announcements	2024-06-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Share Issue/Capital Change	2024-06-06	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE PRELIMINARY CLINICAL DATA ON RELMA-CEL INJECTION IN ADULTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS IN CHINA AT THE EULAR 2024 CONGRESS Regulatory Filings	2024-05-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Share Issue/Capital Change	2024-05-07	English
GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULES 14A.52 AND 14A.53 OF THE LISTING RULES UNDER THE LICENSE AND STRATEGIC ALLIANCE AGREEMENT Regulatory Filings	2024-04-26	English
Form of proxy for the Annual General Meeting to be held on June 18, 2024 AGM Information	2024-04-26	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-04-26	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES, TRANSFER SHARES OUT OF TREASURY AND REPURCHASE SHARES AND RE-ELECTION OF DIRECTORS AND RE-APPOINTMENT OF AUDITOR AND ADOPTION OF NEW MEMORANDUM AND ARTI AGM Information	2024-04-26	English
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION Governance Information	2024-04-26	English
2023 Environmental, Social and Governance Report Environmental & Social Information	2024-04-26	English
2023 ANNUAL REPORT Annual Report FY 2023	2024-04-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Major Shareholding Notification	2024-04-05	English
Next Day Disclosure Return Share Issue/Capital Change	2024-04-02	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF NET PROCEEDS FROM LISTING Annual Report FY 2023	2024-03-20	English
NOTICE OF BOARD MEETING Report Publication Announcement	2024-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Share Issue/Capital Change	2024-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-05	English
Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-01-19	English
Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Report Publication Announcement	2024-01-19	English
VOLUNTARY ANNOUNCEMENT - RESEARCH AND DEVELOPMENT UPDATE - NMPA ACCEPTANCE OF THE SUPPLEMENTAL BIOLOGICAL LICENSE APPLICATION FOR CARTEYVA IN PATIENTS WITH RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA Capital/Financing Update	2024-01-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-04	English
VOLUNTARY ANNOUNCEMENT - STRATEGIC PARTNERSHIP WITH 2SEVENTY BIO, INC. Capital/Financing Update	2024-01-02	English